Records containing: Prostate Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-28Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
-
CLINICAL_TRIALS study record update · 2026-10-28A PHASE 1/2A STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS, AND ANTI-TUMOR ACTIVITY OF PF-07220060 AS A SINGLE AGENT AND AS PART OF COMBINATION THERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS
-
CLINICAL_TRIALS study record update · 2026-10-28Evaluation of the Effectiveness of High-intensity Focused Ultrasound for the Treatment of Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-10-28Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer: a Phase 2, Multicenter, Open-label, Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-10-28To Investigate the Effect of Multidisciplinary Care Approach on Cardiovascular Risk Modification in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study results posted · 2026-10-27Radiopaque Hydrogel Rectal Spacer for Prostate Cancer Radiation Image Guidance
-
CLINICAL_TRIALS study record update · 2026-10-27Phase 3, Multi-Center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Staging Men With Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy With Pelvic Lymph Node Dissection
-
CLINICAL_TRIALS study record update · 2026-10-27Phase 3, Multi-Center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Staging Men With Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy With Pelvic Lymph Node Dissection
-
CLINICAL_TRIALS study record update · 2026-10-27A Survey to Investigate Possible Factors That Will Affect the Choice of Androgen Deprivation Therapy in Prostate Cancer Patients
-
CLINICAL_TRIALS study record update · 2026-10-27BlAck and Mixed Men's Lived Experience With Prostate cANCEr - Diversity in Prostate Cancer PROMS Study
-
CLINICAL_TRIALS study record update · 2026-10-27A Prospective, Phase 2 Clinical Trial of 177Lu-P17-088 Therapy in Patients With Metastatic Androgen Pathway Modulation Resistant Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-10-27Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer: An Open-label, Randomized, Cross-Over Trial.
-
CLINICAL_TRIALS study record update · 2026-10-27A Randomised Controlled Trial Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of Clinically Significant Prostate Cancer: the PROFUSION Trial
-
CLINICAL_TRIALS study record update · 2026-10-27To Identify Potential New Urine Markers for the Screening of Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-10-27The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment
-
CLINICAL_TRIALS study record update · 2026-10-27The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population
-
CLINICAL_TRIALS study record update · 2026-10-27Radiopaque Hydrogel Rectal Spacer for Prostate Cancer Radiation Image Guidance
-
CLINICAL_TRIALS study record update · 2026-10-27The BARCODE 1 Study: The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.
-
CLINICAL_TRIALS study record update · 2026-10-27Phase 3, Multi-Center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Staging Men With Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy With Pelvic Lymph Node Dissection
-
CLINICAL_TRIALS study record update · 2026-10-27The BARCODE 1 Pilot Study: The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening
-
CLINICAL_TRIALS study record update · 2026-10-27Evaluation of the Effectiveness of Irreversible Electroporation for the Treatment of Prostate Cancer
-
CLINICAL_TRIALS study record update · 2026-10-27To Investigate the Diagnostic Accuracy of Exosomal microRNA in Predicting the Aggressiveness of Prostate Cancer in Chinese Patients
-
CLINICAL_TRIALS study record update · 2026-10-27Efficacy of Advanced Radiotherapy (ART) in Prostate Cancer Patients With Early Stage, Advanced, Metastatic and Relapsed Disease (PROST-ART)
-
CLINICAL_TRIALS study record update · 2026-10-27A Novel Augmented Reality System (ARssist) for the Assistant Surgeon in Robotic Assisted Surgery: A Pilot Study
-
CLINICAL_TRIALS study record update · 2026-10-27A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG